DAFNA Capital Management as of March 31, 2019
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 79 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Stereotaxis (STXS) | 11.5 | $27M | 14M | 1.95 | |
| Sage Therapeutics (SAGE) | 8.5 | $20M | 124k | 159.05 | |
| Blueprint Medicines (BPMC) | 4.1 | $9.6M | 120k | 80.05 | |
| AtriCure (ATRC) | 3.7 | $8.5M | 319k | 26.79 | |
| Alder Biopharmaceuticals | 3.4 | $7.8M | 571k | 13.65 | |
| Wave Life Sciences (WVE) | 3.2 | $7.4M | 191k | 38.85 | |
| Aerie Pharmaceuticals | 3.1 | $7.2M | 152k | 47.50 | |
| Zogenix | 3.1 | $7.1M | 130k | 55.01 | |
| iShares NASDAQ Biotechnology Index (IBB) | 3.0 | $6.9M | 61k | 111.81 | |
| Akebia Therapeutics (AKBA) | 2.5 | $5.9M | 716k | 8.19 | |
| Galapagos Nv- (GLPG) | 2.5 | $5.8M | 50k | 117.78 | |
| Ascendis Pharma A S (ASND) | 2.2 | $5.2M | 44k | 117.71 | |
| Neurocrine Biosciences (NBIX) | 2.1 | $4.8M | 55k | 88.10 | |
| Menlo Therapeutics | 2.0 | $4.7M | 600k | 7.85 | |
| Argenx Se (ARGX) | 1.9 | $4.5M | 36k | 124.85 | |
| Bluebird Bio (BLUE) | 1.8 | $4.2M | 27k | 157.33 | |
| Arena Pharmaceuticals | 1.8 | $4.2M | 94k | 44.83 | |
| Biohaven Pharmaceutical Holding | 1.8 | $4.1M | 80k | 51.48 | |
| BioCryst Pharmaceuticals (BCRX) | 1.8 | $4.1M | 498k | 8.14 | |
| Dex (DXCM) | 1.7 | $3.9M | 32k | 119.09 | |
| Cymabay Therapeutics | 1.6 | $3.7M | 279k | 13.28 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 1.6 | $3.6M | 262k | 13.87 | |
| Xenon Pharmaceuticals (XENE) | 1.4 | $3.4M | 331k | 10.16 | |
| Radius Health Inc note 3.000% 9/0 | 1.4 | $3.3M | 4.0M | 0.83 | |
| Cytokinetics (CYTK) | 1.4 | $3.2M | 400k | 8.09 | |
| Luminex Corporation | 1.4 | $3.2M | 138k | 23.01 | |
| Foamix Pharmaceuticals | 1.3 | $3.0M | 808k | 3.75 | |
| Cara Therapeutics (CARA) | 1.2 | $2.8M | 144k | 19.62 | |
| Intec Pharma | 1.2 | $2.8M | 382k | 7.33 | |
| Cardiovascular Systems | 0.9 | $2.2M | 56k | 38.67 | |
| Biotelemetry | 0.9 | $2.2M | 35k | 62.61 | |
| Mersana Therapeutics (MRSN) | 0.9 | $2.1M | 403k | 5.26 | |
| Corbus Pharmaceuticals Hldgs | 0.9 | $2.1M | 305k | 6.95 | |
| Kadmon Hldgs | 0.9 | $2.0M | 757k | 2.64 | |
| Nevro (NVRO) | 0.8 | $2.0M | 31k | 62.51 | |
| Scynexis | 0.8 | $1.9M | 1.3M | 1.51 | |
| Ardelyx (ARDX) | 0.8 | $1.9M | 677k | 2.80 | |
| Achillion Pharmaceuticals | 0.8 | $1.8M | 621k | 2.96 | |
| Dicerna Pharmaceuticals | 0.8 | $1.8M | 123k | 14.65 | |
| Insulet Corp note 1.375% | 0.8 | $1.8M | 1.5M | 1.21 | |
| ArQule | 0.8 | $1.8M | 373k | 4.79 | |
| Viking Therapeutics (VKTX) | 0.8 | $1.8M | 179k | 9.94 | |
| Vbi Vaccines | 0.7 | $1.6M | 850k | 1.87 | |
| Applied Genetic Technol Corp C | 0.7 | $1.5M | 359k | 4.19 | |
| Johnson & Johnson (JNJ) | 0.6 | $1.3M | 9.4k | 139.79 | |
| Advaxis | 0.5 | $1.2M | 202k | 5.91 | |
| Genocea Biosciences | 0.5 | $1.2M | 2.0M | 0.59 | |
| Natus Medical | 0.5 | $1.1M | 43k | 25.38 | |
| Assembly Biosciences | 0.4 | $996k | 51k | 19.69 | |
| Dermira | 0.4 | $969k | 72k | 13.55 | |
| Inogen (INGN) | 0.4 | $944k | 9.9k | 95.35 | |
| Alector (ALEC) | 0.4 | $918k | 49k | 18.71 | |
| Macrogenics (MGNX) | 0.4 | $899k | 50k | 17.98 | |
| Zafgen | 0.4 | $910k | 332k | 2.74 | |
| Spero Therapeutics (SPRO) | 0.4 | $897k | 70k | 12.81 | |
| Arbutus Biopharma (ABUS) | 0.4 | $884k | 247k | 3.58 | |
| Radius Health | 0.4 | $837k | 42k | 19.93 | |
| Madrigal Pharmaceuticals (MDGL) | 0.4 | $827k | 6.6k | 125.30 | |
| Savara (SVRA) | 0.3 | $813k | 110k | 7.37 | |
| Phasebio Pharmaceuticals (PHASQ) | 0.3 | $689k | 73k | 9.50 | |
| Kalvista Pharmaceuticals (KALV) | 0.3 | $665k | 23k | 28.63 | |
| Kura Oncology (KURA) | 0.3 | $606k | 37k | 16.58 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.2 | $564k | 213k | 2.65 | |
| Obseva Sa | 0.2 | $555k | 43k | 12.79 | |
| Urogen Pharma (URGN) | 0.2 | $554k | 15k | 36.93 | |
| Aldeyra Therapeutics (ALDX) | 0.2 | $452k | 50k | 9.04 | |
| Masimo Corporation (MASI) | 0.2 | $415k | 3.0k | 138.33 | |
| Rigel Pharmaceuticals (RIGL) | 0.1 | $354k | 138k | 2.57 | |
| Sutro Biopharma (STRO) | 0.1 | $359k | 32k | 11.40 | |
| Dexcom Inc dbcv 0.750% 5/1 | 0.1 | $335k | 250k | 1.34 | |
| Arcturus Therapeutics | 0.1 | $323k | 47k | 6.84 | |
| Minerva Neurosciences | 0.1 | $284k | 36k | 7.87 | |
| Alder Biopharmaceuticals Inc convertible security | 0.1 | $240k | 250k | 0.96 | |
| Sol Gel Technologies (SLGL) | 0.1 | $237k | 35k | 6.77 | |
| Aileron Therapeutics | 0.1 | $194k | 100k | 1.95 | |
| BioTime | 0.1 | $125k | 95k | 1.31 | |
| Immunomedics | 0.0 | $97k | 5.1k | 19.20 | |
| Oramed Pharm (ORMP) | 0.0 | $95k | 26k | 3.65 | |
| Bellicum Pharma | 0.0 | $101k | 30k | 3.37 |
